PPD is a drug manufacturers - specialty & generic business based in the US. PPD shares (PPD) are listed on the NASDAQ and all prices are listed in US Dollars. PPD employs 30,000 staff and has a trailing 12-month revenue of around $5.9 billion.
Our top picks for where to buy PPD stock
How to buy PPD stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PPD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy PPD stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
PPD stock price (NASDAQ: PPD)
Use our graph to track the performance of PPD stocks over time.PPD shares at a glance
52-week range | $0.00 - $0.00 |
---|---|
50-day moving average | $47.14 |
200-day moving average | $45.20 |
Wall St. target price | $47.14 |
PE ratio | 47.0448 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $1.01 |
Is it a good time to buy PPD stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PPD price performance over time
Historical closes compared with the close of $N/A from 2022-01-07
1 week (2024-07-16) | N/A |
---|---|
1 month (2024-06-23) | N/A |
3 months (2024-04-23) | N/A |
6 months (2024-01-23) | N/A |
1 year (2023-07-23) | N/A |
---|---|
2 years (2022-07-23) | N/A |
3 years (2021-07-27) | -100.00% |
5 years (2019-07-23) | N/A |
Is PPD stock undervalued or overvalued?
Valuing PPD stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PPD's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PPD's P/E ratio
PPD's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, PPD shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PPD's PEG ratio
PPD's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.541. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PPD's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PPD's EBITDA
PPD's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $968.7 million.
The EBITDA is a measure of a PPD's overall financial performance and is widely used to measure a its profitability.
PPD financials
Revenue TTM | $5.9 billion |
---|---|
Operating margin TTM | 11.37% |
Gross profit TTM | $3 billion |
Return on assets TTM | 6.39% |
Return on equity TTM | 0% |
Profit margin | 6.19% |
Book value | N/A |
Market Capitalization | $16.6 billion |
TTM: trailing 12 months
PPD share dividends
We're not expecting PPD to pay a dividend over the next 12 months.
PPD overview
PPD, Inc. , together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform.
Frequently asked questions
nullWhat percentage of PPD is owned by insiders or institutions?
Currently 22.528% of PPD shares are held by insiders and 79.44% by institutions. How many people work for PPD?
Latest data suggests 30,000 work at PPD. When does the fiscal year end for PPD?
PPD's fiscal year ends in December. Where is PPD based?
PPD's address is: 929 North Front Street, Wilmington, NC, United States, 28401-3331 What is PPD's ISIN number?
PPD's international securities identification number is: US69355F1021 What is PPD's CUSIP number?
PPD's Committee on Uniform Securities Identification Procedures number is: 69355F102
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question